SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MLR'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_B_DVAB8_0 (GRAMICIDIN A) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Escherichiacoli;Arachisduranensis) | 3 / 3 | TRP A 158VAL A 259TRP A 340 | NoneNoneMLR A 400 (-3.8A) | 1.23A | 1c4dA-3ob4A:undetectable1c4dB-3ob4A:undetectable | 1c4dA-3ob4A:5.211c4dB-3ob4A:5.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_B_DVAB8_0 (GRAMICIDIN A) |
4pqk | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,TRUNCATEDREPLICATION PROTEINREPA (Escherichiacoli;Staphylococcusaureus) | 3 / 3 | TRP A 159VAL A 260TRP A 341 | NoneNoneMLR A 700 (-4.0A) | 1.25A | 1c4dA-4pqkA:undetectable1c4dB-4pqkA:undetectable | 1c4dA-4pqkA:5.211c4dB-4pqkA:5.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_B_DVAB8_0 (GRAMICIDIN A) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 3 / 3 | TRP A 158VAL A 259TRP A 340 | NoneNoneMLR A 501 (-4.0A) | 1.26A | 1c4dA-5c7rA:undetectable1c4dB-5c7rA:undetectable | 1c4dA-5c7rA:2.381c4dB-5c7rA:2.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_B_DVAB8_0 (GRAMICIDIN A) |
5hz7 | COMP (Neisseriameningitidis) | 3 / 3 | TRP A 159VAL A 260TRP A 341 | NoneNoneMLR A 501 (-3.1A) | 1.30A | 1c4dA-5hz7A:undetectable1c4dB-5hz7A:undetectable | 1c4dA-5hz7A:2.781c4dB-5hz7A:2.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_B_DVAB8_0 (GRAMICIDIN A) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 3 / 3 | TRP A 164VAL A 265TRP A 346 | NoneNoneMLR A 501 (-3.9A) | 1.30A | 1c4dA-5ttdA:undetectable1c4dB-5ttdA:undetectable | 1c4dA-5ttdA:2.551c4dB-5ttdA:2.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9H_A_RAPA108_1 (FKBP12.6) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 5 / 12 | TYR A 213ASP A 217VAL A 113ILE A 229PHE A 159 | MLR A2913 ( 3.8A)NoneNoneNoneMLR A2913 (-4.6A) | 1.07A | 1c9hA-2fncA:undetectable | 1c9hA-2fncA:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) |
5h05 | AMYP (marinemetagenome) | 5 / 12 | TYR A 89ASP A 178HIS A 296ASP A 297ARG A 371 | MLR A 701 (-4.0A)MLR A 701 (-3.0A)MLR A 701 (-4.0A)MLR A 701 (-2.9A)MLR A 701 (-2.9A) | 0.68A | 1dedA-5h05A:33.1 | 1dedA-5h05A:25.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) |
5h05 | AMYP (marinemetagenome) | 6 / 12 | TYR A 89ARG A 176ASP A 178HIS A 296ASP A 297ARG A 371 | MLR A 701 (-4.0A)MLR A 701 (-3.7A)MLR A 701 (-3.0A)MLR A 701 (-4.0A)MLR A 701 (-2.9A)MLR A 701 (-2.9A) | 0.58A | 1dedB-5h05A:36.1 | 1dedB-5h05A:25.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E71_M_ASCM995_0 (MYROSINASE MA1) |
1urd | MALTOSE-BINDINGPROTEIN (Alicyclobacillusacidocaldarius) | 4 / 7 | GLN A 141ILE A 288PHE A 73PHE A 180 | MLR A1400 (-3.1A)NoneMLR A1400 (-4.6A)None | 1.14A | 1e71M-1urdA:undetectable | 1e71M-1urdA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E72_M_ASCM995_0 (MYROSINASE MA1) |
1urd | MALTOSE-BINDINGPROTEIN (Alicyclobacillusacidocaldarius) | 4 / 7 | GLN A 141ILE A 288PHE A 73PHE A 180 | MLR A1400 (-3.1A)NoneMLR A1400 (-4.6A)None | 1.17A | 1e72M-1urdA:undetectable | 1e72M-1urdA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E73_M_ASCM995_0 (MYROSINASE MA1) |
1urd | MALTOSE-BINDINGPROTEIN (Alicyclobacillusacidocaldarius) | 4 / 6 | GLN A 141ILE A 288PHE A 73PHE A 180 | MLR A1400 (-3.1A)NoneMLR A1400 (-4.6A)None | 1.14A | 1e73M-1urdA:0.0 | 1e73M-1urdA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E7A_B_PFLB4002_1 (SERUM ALBUMIN) |
1urd | MALTOSE-BINDINGPROTEIN (Alicyclobacillusacidocaldarius) | 4 / 6 | LEU A 309VAL A 34SER A 36GLN A 38 | NoneNoneNoneMLR A1400 (-3.0A) | 1.01A | 1e7aB-1urdA:0.9 | 1e7aB-1urdA:19.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FIQ_C_SALC1335_1 (XANTHINE OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 8 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.31A | 1fiqC-2gh9A:undetectable | 1fiqC-2gh9A:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FO4_A_SALA3005_1 (XANTHINEDEHYDROGENASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.32A | 1fo4A-2gh9A:0.0 | 1fo4A-2gh9A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JQD_A_HSMA600_1 (HISTAMINEN-METHYLTRANSFERASE) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 7 | PHE A 273GLU A 76GLN A 28VAL A 303 | NoneMLR A 401 ( 4.4A)MLR A 401 ( 4.1A)None | 1.44A | 1jqdA-5m28A:undetectable | 1jqdA-5m28A:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MXD_A_ACRA735_1 (ALPHA AMYLASE) |
5h05 | AMYP (marinemetagenome) | 7 / 12 | TYR A 89HIS A 129ARG A 176ASP A 178TRP A 223HIS A 296ASP A 297 | MLR A 701 (-4.0A)MLR A 701 (-4.2A)MLR A 701 (-3.7A)MLR A 701 (-3.0A)NoneMLR A 701 (-4.0A)MLR A 701 (-2.9A) | 0.35A | 1mxdA-5h05A:26.8 | 1mxdA-5h05A:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_2 (ISOLEUCYL-TRNASYNTHETASE) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 3 / 3 | GLU A 112TRP A 231LYS A 274 | MLR A 500 (-2.2A)MLR A 500 (-4.2A)None | 1.20A | 1qu2A-4edqA:undetectable | 1qu2A-4edqA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_2 (ISOLEUCYL-TRNASYNTHETASE) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 3 / 3 | GLU A 111TRP A 230LYS A 273 | MLR A1201 (-3.1A)MLR A1201 (-4.4A)None | 1.19A | 1qu2A-4xa2A:undetectable | 1qu2A-4xa2A:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QU2_A_MRCA1993_2 (ISOLEUCYL-TRNASYNTHETASE) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 3 / 3 | GLU A 117TRP A 236LYS A 279 | MLR A 501 (-2.8A)MLR A 501 ( 4.6A)None | 1.30A | 1qu2A-5ttdA:undetectable | 1qu2A-5ttdA:20.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERASE) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 5 / 10 | LEU N 192LEU N 195ILE N 161GLU N 153LEU N 151 | NoneNoneNoneMLR N2001 (-3.2A)None | 1.24A | 1wopA-3o3uN:undetectable | 1wopA-3o3uN:22.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERASE) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Escherichiacoli;Homosapiens;Deltapapillomavirus4) | 5 / 10 | LEU A 193LEU A 196ILE A 162GLU A 154LEU A 152 | NoneNoneNoneMLR A 701 (-3.2A)None | 1.21A | 1wopA-3py7A:undetectable | 1wopA-3py7A:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERASE) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 5 / 10 | LEU A 193LEU A 196ILE A 162GLU A 154LEU A 152 | NoneNoneNoneMLR A 500 (-3.0A)None | 1.25A | 1wopA-4edqA:undetectable | 1wopA-4edqA:22.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERASE) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 5 / 10 | LEU A 198LEU A 201ILE A 167GLU A 159LEU A 157 | NoneNoneNoneMLR A 501 (-2.8A)None | 1.21A | 1wopA-5ttdA:undetectable | 1wopA-5ttdA:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AOX_A_THAA400_1 (HISTAMINEN-METHYLTRANSFERASE) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 8 | PHE A 125GLU A 76GLN A 28TYR A 31 | NoneMLR A 401 ( 4.4A)MLR A 401 ( 4.1A)None | 1.04A | 2aoxA-5m28A:undetectable | 2aoxA-5m28A:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AOX_A_THAA400_1 (HISTAMINEN-METHYLTRANSFERASE) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 8 | PHE A 273GLU A 76GLN A 28TYR A 31 | NoneMLR A 401 ( 4.4A)MLR A 401 ( 4.1A)None | 1.14A | 2aoxA-5m28A:undetectable | 2aoxA-5m28A:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 5 / 11 | TYR A 213ASP A 217VAL A 113ILE A 229PHE A 159 | MLR A2913 ( 3.8A)NoneNoneNoneMLR A2913 (-4.6A) | 1.06A | 2dg4A-2fncA:undetectable | 2dg4A-2fncA:15.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMJ_A_ACRA1001_2 (MALTASE-GLUCOAMYLASE, INTESTINAL) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 6 | THR A 184TYR A 167TRP A 353THR A 181 | NoneNoneMLR A 401 (-2.6A)None | 1.37A | 2qmjA-5m28A:undetectable | 2qmjA-5m28A:17.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VE3_B_REAB1445_1 (PUTATIVE CYTOCHROMEP450 120) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 12 | ALA A 56ALA A 283VAL A 271GLY A 270GLN A 269 | NoneNoneNoneNoneMLR A2913 (-4.3A) | 1.28A | 2ve3B-2gh9A:undetectable | 2ve3B-2gh9A:21.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_A_SAMA801_1 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 4 / 8 | THR A 94LEU A 286ASP A 288GLU A 112 | NoneNoneNoneMLR A 500 (-2.2A) | 1.02A | 2zw9A-4edqA:undetectable | 2zw9A-4edqA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_A_SAMA801_1 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 4 / 8 | THR A 99LEU A 291ASP A 293GLU A 117 | NoneNoneNoneMLR A 501 (-2.8A) | 0.98A | 2zw9A-5ttdA:undetectable | 2zw9A-5ttdA:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AX9_A_SALA1341_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 8 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.33A | 3ax9A-2gh9A:undetectable | 3ax9A-2gh9A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_C_SAMC300_1 (PUTATIVE RRNAMETHYLASE) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 3 / 3 | ASN A 230ASP A 301GLN A 15 | NoneNoneMLR A2913 ( 3.9A) | 0.79A | 3eeyC-2fncA:undetectable | 3eeyC-2fncA:24.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_D_SAMD300_1 (PUTATIVE RRNAMETHYLASE) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 3 / 3 | ASN A 230ASP A 301GLN A 15 | NoneNoneMLR A2913 ( 3.9A) | 0.79A | 3eeyD-2fncA:undetectable | 3eeyD-2fncA:24.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 12 / 12 | ASP N 14LYS N 15LYS N 42GLU N 44GLU N 45ALA N 63ASP N 65ARG N 66GLU N 111PRO N 154TRP N 230TYR N 341 | MLR N2001 (-3.0A)MLR N2001 (-2.8A)NoneMLR N2001 (-3.6A)MLR N2001 (-4.1A)MLR N2001 (-3.3A)MLR N2001 (-2.9A)MLR N2001 (-3.9A)MLR N2001 (-2.9A)MLR N2001 (-3.5A)MLR N2001 (-4.4A)MLR N2001 (-4.4A) | 0.24A | 3jyrA-3o3uN:63.3 | 3jyrA-3o3uN:71.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 12 / 12 | ASP A 14LYS A 15LYS A 42GLU A 44GLU A 45ALA A 63ASP A 65ARG A 66GLU A 111PRO A 154TRP A 230TYR A 341 | MLR A 400 (-3.1A)MLR A 400 (-2.6A)NoneMLR A 400 (-3.8A)MLR A 400 ( 4.6A)MLR A 400 (-2.9A)MLR A 400 (-2.7A)MLR A 400 (-3.8A)MLR A 400 (-2.7A)MLR A 400 (-3.7A)MLR A 400 (-4.3A)MLR A 400 (-4.7A) | 0.41A | 3jyrA-3ob4A:62.3 | 3jyrA-3ob4A:68.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Deltapapillomavirus4;Escherichiacoli;Homosapiens) | 12 / 12 | ASP A 15LYS A 16LYS A 43GLU A 45GLU A 46ALA A 64ASP A 66ARG A 67GLU A 112PRO A 155TRP A 231TYR A 342 | MLR A 701 (-3.0A)MLR A 701 (-2.7A)NoneMLR A 701 (-3.6A)MLR A 701 (-4.2A)MLR A 701 (-3.3A)MLR A 701 (-2.8A)MLR A 701 (-3.8A)MLR A 701 (-3.0A)MLR A 701 (-3.6A)MLR A 701 ( 4.5A)MLR A 701 (-4.3A) | 0.37A | 3jyrA-3py7A:62.9 | 3jyrA-3py7A:68.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 12 / 12 | ASP A 15LYS A 16LYS A 43GLU A 45GLU A 46ALA A 64ASP A 66ARG A 67GLU A 112PRO A 155TRP A 231TYR A 342 | MLR A 500 (-1.9A)MLR A 500 (-2.7A)NoneMLR A 500 (-2.6A)MLR A 500 (-3.4A)MLR A 500 (-2.8A)MLR A 500 (-2.1A)MLR A 500 (-3.6A)MLR A 500 (-2.2A)MLR A 500 (-3.0A)MLR A 500 (-4.2A)MLR A 500 (-3.7A) | 0.23A | 3jyrA-4edqA:60.8 | 3jyrA-4edqA:71.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4pqk | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,TRUNCATEDREPLICATION PROTEINREPA (Escherichiacoli;Staphylococcusaureus) | 12 / 12 | ASP A 15LYS A 16LYS A 43GLU A 45GLU A 46ALA A 64ASP A 66ARG A 67GLU A 112PRO A 155TRP A 231TYR A 342 | MLR A 700 (-3.0A)MLR A 700 (-2.5A)NoneMLR A 700 (-3.2A)MLR A 700 (-4.1A)MLR A 700 (-3.2A)MLR A 700 (-2.7A)MLR A 700 (-2.9A)MLR A 700 (-3.0A)MLR A 700 (-3.6A)MLR A 700 (-4.4A)MLR A 700 (-3.9A) | 0.45A | 3jyrA-4pqkA:54.4 | 3jyrA-4pqkA:76.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 11 / 12 | ASP A 14LYS A 15GLU A 44GLU A 45ALA A 63ASP A 65ARG A 66GLU A 111PRO A 154TRP A 230TYR A 341 | MLR A1201 (-3.2A)MLR A1201 (-2.9A)MLR A1201 (-3.5A)MLR A1201 (-3.8A)MLR A1201 (-3.3A)MLR A1201 (-2.9A)MLR A1201 (-4.0A)MLR A1201 (-3.1A)MLR A1201 (-3.5A)MLR A1201 (-4.4A)MLR A1201 (-4.1A) | 0.34A | 3jyrA-4xa2A:62.4 | 3jyrA-4xa2A:73.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 12 / 12 | ASP A 14LYS A 15LYS A 42GLU A 44GLU A 45ALA A 63ASP A 65ARG A 66GLU A 111PRO A 154TRP A 230TYR A 341 | MLR A 501 (-2.9A)MLR A 501 (-2.6A)NoneMLR A 501 (-3.8A)MLR A 501 (-4.2A)MLR A 501 (-3.2A)MLR A 501 (-2.8A)MLR A 501 (-3.5A)MLR A 501 (-2.9A)MLR A 501 (-3.4A)MLR A 501 ( 4.5A)MLR A 501 ( 4.3A) | 0.37A | 3jyrA-5c7rA:62.7 | 3jyrA-5c7rA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5hz7 | COMP (Neisseriameningitidis) | 12 / 12 | ASP A 15LYS A 16LYS A 43GLU A 45GLU A 46ALA A 64ASP A 66ARG A 67GLU A 112PRO A 155TRP A 231TYR A 342 | MLR A 501 (-2.2A)MLR A 501 (-2.6A)BGC A 504 (-2.5A)BGC A 504 ( 2.4A)BGC A 504 (-2.2A)MLR A 501 (-3.0A)MLR A 501 (-2.8A)MLR A 501 (-3.8A)MLR A 501 (-2.4A)MLR A 501 (-2.6A)MLR A 501 (-3.3A)MLR A 501 ( 3.4A) | 0.30A | 3jyrA-5hz7A:62.8 | 3jyrA-5hz7A:66.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 10 / 12 | ASP A 20LYS A 21GLU A 50GLU A 51ALA A 69ASP A 71ARG A 72GLU A 117PRO A 160TRP A 236 | MLR A 501 (-3.0A)MLR A 501 (-2.5A)MLR A 501 (-3.9A)MLR A 501 (-3.8A)MLR A 501 (-3.3A)MLR A 501 (-2.8A)MLR A 501 (-3.6A)MLR A 501 (-2.8A)MLR A 501 (-3.6A)MLR A 501 ( 4.6A) | 0.35A | 3jyrA-5ttdA:61.3 | 3jyrA-5ttdA:66.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 7 / 7 | ASN N 12TRP N 62GLU N 153TYR N 155MET N 330TRP N 340ARG N 344 | MLR N2001 ( 4.7A)MLR N2001 (-4.3A)MLR N2001 (-3.2A)MLR N2001 (-3.8A)MLR N2001 ( 4.3A)MLR N2001 (-3.8A)None | 0.18A | 3jyrA-3o3uN:63.3 | 3jyrA-3o3uN:71.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 6 / 7 | ASN A 12TRP A 62GLU A 153TYR A 155MET A 330TRP A 340 | MLR A 400 ( 4.9A)MLR A 400 (-4.5A)MLR A 400 (-2.9A)MLR A 400 (-4.0A)MLR A 400 (-4.3A)MLR A 400 (-3.8A) | 0.27A | 3jyrA-3ob4A:62.3 | 3jyrA-3ob4A:68.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 6 / 7 | ASN A 12TRP A 62TYR A 155MET A 330TRP A 340ARG A 344 | MLR A 400 ( 4.9A)MLR A 400 (-4.5A)MLR A 400 (-4.0A)MLR A 400 (-4.3A)MLR A 400 (-3.8A)None | 0.62A | 3jyrA-3ob4A:62.3 | 3jyrA-3ob4A:68.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Deltapapillomavirus4;Escherichiacoli;Homosapiens) | 7 / 7 | ASN A 13TRP A 63GLU A 154TYR A 156MET A 331TRP A 341ARG A 345 | MLR A 701 ( 4.6A)MLR A 701 (-4.4A)MLR A 701 (-3.2A)MLR A 701 (-3.8A)MLR A 701 ( 4.2A)MLR A 701 (-4.0A)None | 0.23A | 3jyrA-3py7A:62.9 | 3jyrA-3py7A:68.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 6 / 7 | ASN A 13TRP A 63GLU A 154TYR A 156MET A 331TRP A 341 | MLR A 500 (-4.6A)MLR A 500 (-4.2A)MLR A 500 (-3.0A)MLR A 500 (-2.9A)MLR A 500 ( 3.5A)MLR A 500 (-2.9A) | 0.22A | 3jyrA-4edqA:60.8 | 3jyrA-4edqA:71.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4pqk | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,TRUNCATEDREPLICATION PROTEINREPA (Escherichiacoli;Staphylococcusaureus) | 6 / 7 | ASN A 13TRP A 63GLU A 154TYR A 156MET A 331TRP A 341 | MLR A 700 (-4.7A)MLR A 700 (-4.6A)MLR A 700 (-4.0A)MLR A 700 (-3.8A)MLR A 700 (-4.1A)MLR A 700 (-4.0A) | 0.42A | 3jyrA-4pqkA:54.4 | 3jyrA-4pqkA:76.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 6 / 7 | ASN A 12TRP A 62GLU A 153TYR A 155MET A 330TRP A 340 | MLR A1201 ( 4.7A)MLR A1201 (-4.4A)MLR A1201 (-3.2A)MLR A1201 (-3.8A)MLR A1201 ( 4.4A)MLR A1201 (-4.1A) | 0.21A | 3jyrA-4xa2A:62.4 | 3jyrA-4xa2A:73.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 6 / 7 | ASN A 12TRP A 62GLU A 153TYR A 155MET A 330TRP A 340 | MLR A 501 (-4.7A)MLR A 501 (-4.5A)MLR A 501 (-3.2A)MLR A 501 (-3.9A)MLR A 501 ( 4.3A)MLR A 501 (-4.0A) | 0.14A | 3jyrA-5c7rA:62.7 | 3jyrA-5c7rA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 6 / 7 | ASN A 12TRP A 62TYR A 155MET A 330TRP A 340ARG A 344 | MLR A 501 (-4.7A)MLR A 501 (-4.5A)MLR A 501 (-3.9A)MLR A 501 ( 4.3A)MLR A 501 (-4.0A)None | 0.57A | 3jyrA-5c7rA:62.7 | 3jyrA-5c7rA:76.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5hz7 | COMP (Neisseriameningitidis) | 6 / 7 | ASN A 13TRP A 63GLU A 154TYR A 156MET A 331TRP A 341 | MLR A 501 ( 4.6A)MLR A 501 (-4.0A)MLR A 501 (-2.6A)MLR A 501 (-2.8A)MLR A 501 (-3.7A)MLR A 501 (-3.1A) | 0.18A | 3jyrA-5hz7A:62.8 | 3jyrA-5hz7A:66.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5hz7 | COMP (Neisseriameningitidis) | 6 / 7 | ASN A 13TRP A 63TYR A 156MET A 331TRP A 341ARG A 345 | MLR A 501 ( 4.6A)MLR A 501 (-4.0A)MLR A 501 (-2.8A)MLR A 501 (-3.7A)MLR A 501 (-3.1A)BGC A 504 ( 3.9A) | 0.60A | 3jyrA-5hz7A:62.8 | 3jyrA-5hz7A:66.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 6 / 7 | ASN A 18TRP A 68GLU A 159TYR A 161MET A 336TRP A 346 | MLR A 501 (-4.2A)MLR A 501 (-4.4A)MLR A 501 (-2.8A)MLR A 501 (-3.9A)MLR A 501 ( 4.4A)MLR A 501 (-3.9A) | 0.22A | 3jyrA-5ttdA:61.3 | 3jyrA-5ttdA:66.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 6 / 7 | ASN A 18TRP A 68TYR A 161MET A 336TRP A 346ARG A 350 | MLR A 501 (-4.2A)MLR A 501 (-4.4A)MLR A 501 (-3.9A)MLR A 501 ( 4.4A)MLR A 501 (-3.9A)MLR A 501 (-4.8A) | 0.58A | 3jyrA-5ttdA:61.3 | 3jyrA-5ttdA:66.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SPK_B_TPVB100_1 (HIV-1 PROTEASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | ARG A 305ASN A 300VAL A 313GLY A 324ILE A 249 | MLR A2913 (-3.0A)NoneNoneNoneNone | 1.30A | 3spkA-2gh9A:undetectable | 3spkA-2gh9A:15.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 5 / 12 | PHE N 156GLY N 300LEU N 299GLU N 111ALA N 231 | NoneNoneNoneMLR N2001 (-2.9A)None | 0.84A | 3tbgB-3o3uN:undetectable | 3tbgB-3o3uN:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A 400 (-2.7A)None | 0.87A | 3tbgB-3ob4A:undetectable | 3tbgB-3ob4A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Deltapapillomavirus4;Escherichiacoli;Homosapiens) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | NoneNoneNoneMLR A 701 (-3.0A)None | 0.86A | 3tbgB-3py7A:undetectable | 3tbgB-3py7A:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | MLR A 500 (-4.0A)NoneNoneMLR A 500 (-2.2A)None | 0.86A | 3tbgB-4edqA:undetectable | 3tbgB-4edqA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A1201 (-3.1A)None | 0.84A | 3tbgB-4xa2A:undetectable | 3tbgB-4xa2A:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A 501 (-2.9A)None | 0.88A | 3tbgB-5c7rA:undetectable | 3tbgB-5c7rA:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
5hz7 | COMP (Neisseriameningitidis) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | MLR A 501 ( 4.2A) NA A 507 (-3.5A)NoneMLR A 501 (-2.4A)None | 0.85A | 3tbgB-5hz7A:undetectable | 3tbgB-5hz7A:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 5 / 12 | PHE A 162GLY A 306LEU A 305GLU A 117ALA A 237 | NoneNoneNoneMLR A 501 (-2.8A)None | 0.85A | 3tbgB-5ttdA:undetectable | 3tbgB-5ttdA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 5 / 12 | PHE N 156GLY N 300LEU N 299GLU N 111ALA N 231 | NoneNoneNoneMLR N2001 (-2.9A)None | 0.83A | 3tbgD-3o3uN:undetectable | 3tbgD-3o3uN:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A 400 (-2.7A)None | 0.85A | 3tbgD-3ob4A:undetectable | 3tbgD-3ob4A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Deltapapillomavirus4;Escherichiacoli;Homosapiens) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | NoneNoneNoneMLR A 701 (-3.0A)None | 0.83A | 3tbgD-3py7A:undetectable | 3tbgD-3py7A:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | MLR A 500 (-4.0A)NoneNoneMLR A 500 (-2.2A)None | 0.85A | 3tbgD-4edqA:undetectable | 3tbgD-4edqA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A1201 (-3.1A)None | 0.82A | 3tbgD-4xa2A:undetectable | 3tbgD-4xa2A:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 5 / 12 | PHE A 156GLY A 300LEU A 299GLU A 111ALA A 231 | NoneNoneNoneMLR A 501 (-2.9A)None | 0.86A | 3tbgD-5c7rA:undetectable | 3tbgD-5c7rA:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
5hz7 | COMP (Neisseriameningitidis) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | MLR A 501 ( 4.2A) NA A 507 (-3.5A)NoneMLR A 501 (-2.4A)None | 0.83A | 3tbgD-5hz7A:undetectable | 3tbgD-5hz7A:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
5ttd | MALTOSE-BINDINGPERIPLASMICPROTEIN,PILINISOPEPTIDE LINKAGEDOMAIN PROTEIN (Escherichiacoli;Streptococcuspyogenes) | 5 / 12 | PHE A 162GLY A 306LEU A 305GLU A 117ALA A 237 | NoneNoneNoneMLR A 501 (-2.8A)None | 0.84A | 3tbgD-5ttdA:undetectable | 3tbgD-5ttdA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNA_A_SALA1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.32A | 3unaA-2gh9A:undetectable | 3unaA-2gh9A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNA_B_SALB1340_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.31A | 3unaB-2gh9A:0.0 | 3unaB-2gh9A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNC_A_SALA1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.32A | 3uncA-2gh9A:0.0 | 3uncA-2gh9A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNC_B_SALB1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2gh9 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Thermusthermophilus) | 5 / 9 | LEU A 296ARG A 305PHE A 111THR A 61VAL A 271 | NoneMLR A2913 (-3.0A)NoneNoneNone | 1.31A | 3uncB-2gh9A:0.0 | 3uncB-2gh9A:15.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BQF_A_QPSA951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 6 | MET A 352TRP A 363GLU A 407ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.31A | 4bqfA-4bqiA:64.3 | 4bqfA-4bqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BQF_A_QPSA951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 6 / 6 | MET A 356GLY A 362TRP A 363ARG A 400GLU A 407ARG A 411 | MLR A 951 ( 3.7A)MLR A 951 (-3.6A)NoneMLR A 951 (-2.9A)MLR A 951 (-2.9A)MLR A 951 (-4.1A) | 0.19A | 4bqfA-4bqiA:64.3 | 4bqfA-4bqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 8 / 8 | ARG A 217MET A 356TRP A 363ARG A 400GLU A 403GLU A 407LYS A 410ARG A 411 | MLR A 951 (-3.8A)MLR A 951 ( 3.7A)NoneMLR A 951 (-2.9A)MLR A 951 ( 3.9A)MLR A 951 (-2.9A)MLR A 951 ( 4.4A)MLR A 951 (-4.1A) | 0.20A | 4bqfB-4bqiA:63.6 | 4bqfB-4bqiA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J4V_D_SVRD301_1 (NUCLEOCAPSID PROTEIN) |
5h05 | AMYP (marinemetagenome) | 5 / 11 | GLY A 128ARG A 176ALA A 220VAL A 183PRO A 143 | NoneMLR A 701 (-3.7A)NoneNoneNone | 1.36A | 4j4vD-5h05A:undetectable4j4vE-5h05A:undetectable | 4j4vD-5h05A:17.834j4vE-5h05A:17.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 4 / 5 | ASN N 267ALA N 51GLY N 56ASP N 14 | NoneNoneNoneMLR N2001 (-3.0A) | 0.95A | 4n48A-3o3uN:undetectable | 4n48A-3o3uN:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Escherichiacoli;Arachisduranensis) | 4 / 5 | ASN A 267ALA A 51GLY A 56ASP A 14 | NoneNoneNoneMLR A 400 (-3.1A) | 0.98A | 4n48A-3ob4A:undetectable | 4n48A-3ob4A:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Escherichiacoli;Homosapiens;Deltapapillomavirus4) | 4 / 5 | ASN A 268ALA A 52GLY A 57ASP A 15 | NoneNoneNoneMLR A 701 (-3.0A) | 0.99A | 4n48A-3py7A:undetectable | 4n48A-3py7A:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
5hz7 | COMP (Neisseriameningitidis) | 4 / 5 | ASN A 268ALA A 52GLY A 57ASP A 15 | NoneNoneNoneMLR A 501 (-2.2A) | 0.97A | 4n48A-5hz7A:undetectable | 4n48A-5hz7A:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UAC_A_ACRA501_1 (CARBOHYDRATE ABCTRANSPORTERSUBSTRATE-BINDINGPROTEIN, CUT1 FAMILY(TC 3.A.1.1.-)) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 5 / 12 | LYS A 45ALA A 64ASP A 66ASN A 156TRP A 233 | NoneMLR A2913 (-3.1A)MLR A2913 (-2.8A)MLR A2913 (-2.7A)MLR A2913 (-4.0A) | 0.83A | 4uacA-2fncA:37.3 | 4uacA-2fncA:24.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UAC_A_ACRA501_1 (CARBOHYDRATE ABCTRANSPORTERSUBSTRATE-BINDINGPROTEIN, CUT1 FAMILY(TC 3.A.1.1.-)) |
5m28 | MALE1 (Lactobacilluscasei) | 5 / 12 | ALA A 78ASP A 80GLN A 81ASN A 162TRP A 234 | MLR A 401 (-3.0A)MLR A 401 (-2.1A)MLR A 401 (-3.9A)MLR A 401 (-3.3A)MLR A 401 (-2.8A) | 0.55A | 4uacA-5m28A:46.2 | 4uacA-5m28A:33.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z2E_H_TR6H101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BSYMMETRIZED E-SITEDNA) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 3 / 5 | GLY A 360GLY A 362GLU A 365 | NoneMLR A 951 (-3.6A)None | 0.42A | 4z2eA-4bqiA:undetectable4z2eD-4bqiA:2.7 | 4z2eA-4bqiA:19.004z2eD-4bqiA:16.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZGF_A_BEZA210_0 (UNCHARACTERIZEDPROTEIN) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 4 | VAL A 64ALA A 60ASN A 59GLN A 81 | NoneNoneNoneMLR A 401 (-3.9A) | 1.45A | 4zgfA-5m28A:undetectable | 4zgfA-5m28A:18.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AMK_A_EF2A151_1 (CEREBLON ISOFORM 4) |
5h05 | AMYP (marinemetagenome) | 4 / 8 | ASN A 148PRO A 149PHE A 90TYR A 94 | NoneNoneMLR A 701 (-4.5A)None | 1.11A | 5amkA-5h05A:undetectable | 5amkA-5h05A:12.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 5 / 12 | TYR A 213ASP A 217VAL A 113ILE A 229PHE A 159 | MLR A2913 ( 3.8A)NoneNoneNoneMLR A2913 (-4.6A) | 1.04A | 5hkgA-2fncA:undetectable | 5hkgA-2fncA:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KIR_B_RCXB601_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Arachisduranensis;Escherichiacoli) | 4 / 4 | LEU A 76ARG A 66ILE A 60PHE A 47 | NoneMLR A 400 (-3.8A)NoneNone | 1.27A | 5kirB-3ob4A:undetectable | 5kirB-3ob4A:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KIR_B_RCXB601_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 4 / 4 | LEU A 76ARG A 66ILE A 60PHE A 47 | NoneMLR A 501 (-3.5A)NoneNone | 1.30A | 5kirB-5c7rA:undetectable | 5kirB-5c7rA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NU7_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 4) |
2fnc | MALTOSE ABCTRANSPORTER,PERIPLASMICMALTOSE-BINDINGPROTEIN (Thermotogamaritima) | 4 / 8 | ALA A 289VAL A 36TYR A 108GLN A 15 | NoneNoneNoneMLR A2913 ( 3.9A) | 0.83A | 5nu7A-2fncA:undetectable | 5nu7A-2fncA:17.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AG0_A_ACRA610_0 (ALPHA-AMYLASE) |
5h05 | AMYP (marinemetagenome) | 5 / 12 | TYR A 89HIS A 129ASP A 178HIS A 296ASP A 297 | MLR A 701 (-4.0A)MLR A 701 (-4.2A)MLR A 701 (-3.0A)MLR A 701 (-4.0A)MLR A 701 (-2.9A) | 0.55A | 6ag0A-5h05A:24.9 | 6ag0A-5h05A:7.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
3o3u | MALTOSE-BINDINGPERIPLASMIC PROTEIN,ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Escherichiacoli;Homosapiens) | 3 / 3 | TYR N 155ASN N 227LEU N 113 | MLR N2001 (-3.8A)NoneNone | 0.81A | 6b58A-3o3uN:undetectable | 6b58A-3o3uN:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
3ob4 | MALTOSE ABCTRANSPORTERPERIPLASMIC PROTEIN,ARAH 2 (Escherichiacoli;Arachisduranensis) | 3 / 3 | TYR A 155ASN A 227LEU A 113 | MLR A 400 (-4.0A)NoneNone | 0.77A | 6b58A-3ob4A:undetectable | 6b58A-3ob4A:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
3py7 | MALTOSE-BINDINGPERIPLASMICPROTEIN,PAXILLINLD1,PROTEIN E6CHIMERA (Escherichiacoli;Homosapiens;Deltapapillomavirus4) | 3 / 3 | TYR A 156ASN A 228LEU A 114 | MLR A 701 (-3.8A)NoneNone | 0.82A | 6b58A-3py7A:undetectable | 6b58A-3py7A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
4edq | MALTOSE-BINDINGPERIPLASMICPROTEIN,MYOSIN-BINDING PROTEIN C,CARDIAC-TYPECHIMERIC PROTEIN (Escherichiacoli;Musmusculus) | 3 / 3 | TYR A 156ASN A 228LEU A 114 | MLR A 500 (-2.9A)NoneNone | 0.79A | 6b58A-4edqA:undetectable | 6b58A-4edqA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
4xa2 | MALTOSE-BINDINGPERIPLASMICPROTEIN,MBP-PILA: C (Acinetobacterbaumannii;Escherichiacoli) | 3 / 3 | TYR A 155ASN A 227LEU A 113 | MLR A1201 (-3.8A)NoneNone | 0.82A | 6b58A-4xa2A:undetectable | 6b58A-4xa2A:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
5c7r | FUSION PROTEIN OFMALTOSE-BINDINGPERIPLASMIC PROTEINAND TYPE-3ICE-STRUCTURINGPROTEIN HPLC 12 (Escherichiacoli;Zoarcesamericanus) | 3 / 3 | TYR A 155ASN A 227LEU A 113 | MLR A 501 (-3.9A)NoneNone | 0.79A | 6b58A-5c7rA:undetectable | 6b58A-5c7rA:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B58_A_ACTA603_0 (FUMARATE REDUCTASEFLAVOPROTEIN SUBUNIT) |
5hz7 | COMP (Neisseriameningitidis) | 3 / 3 | TYR A 156ASN A 228LEU A 114 | MLR A 501 (-2.8A)NoneNone | 0.84A | 6b58A-5hz7A:undetectable | 6b58A-5hz7A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DJZ_B_GMJB301_1 (SIGMA NON-OPIOIDINTRACELLULARRECEPTOR 1) |
5m28 | MALE1 (Lactobacilluscasei) | 4 / 6 | TYR A 164GLN A 81VAL A 77ALA A 266 | MLR A 401 (-2.8A)MLR A 401 (-3.9A)NoneNone | 1.23A | 6djzB-5m28A:undetectable | 6djzB-5m28A:19.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_B_TA1B501_2 (TUBULIN BETA CHAIN) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 5 | LEU A 309THR A 345ARG A 400ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.00A | 6ew0B-4bqiA:undetectable | 6ew0B-4bqiA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_D_TA1D501_2 (TUBULIN BETA CHAIN) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 5 | LEU A 309THR A 345ARG A 400ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.01A | 6ew0D-4bqiA:undetectable | 6ew0D-4bqiA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_G_TA1G501_2 (TUBULIN BETA CHAIN) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 6 | LEU A 309THR A 345ARG A 400ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.01A | 6ew0G-4bqiA:undetectable | 6ew0G-4bqiA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_H_TA1H501_2 (TUBULIN BETA CHAIN) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 5 | LEU A 309THR A 345ARG A 400ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.01A | 6ew0H-4bqiA:undetectable | 6ew0H-4bqiA:7.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_I_TA1I501_2 (TUBULIN BETA CHAIN) |
4bqi | ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC (Arabidopsisthaliana) | 4 / 5 | LEU A 309THR A 345ARG A 400ARG A 411 | NoneNoneMLR A 951 (-2.9A)MLR A 951 (-4.1A) | 1.01A | 6ew0I-4bqiA:undetectable | 6ew0I-4bqiA:7.21 |